Clinical Trial Update: UCMSC Transplantation in the Treatment of Cartilage Damage [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on transplantation of umbilical cord mesenchymal stem cells (UCMSC) for cartilage damage and osteoarthritis in Phase 1/2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Damage
• Osteoarthritis

Drugs mentioned

• UCMSC (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: South China Research Center for Stem Cell and Regenerative Medicine | Conditions: Cartilage Damage, Degenerative Osteoarthritis | Phase 1, Phase 2 | Status: UNKNOWN